Chongqing Lummy Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 874.25 million compared to CNY 865.46 million a year ago. Revenue was CNY 895.59 million compared to CNY 884.59 million a year ago.

Net loss was CNY 8.93 million compared to CNY 68.71 million a year ago. Basic loss per share from continuing operations was CNY 0.0085 compared to CNY 0.0651 a year ago. Diluted loss per share from continuing operations was CNY 0.0085 compared to CNY 0.0651 a year ago.